Filing Details
- Accession Number:
- 0000886744-19-000050
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-04-10 19:45:47
- Reporting Period:
- 2019-04-09
- Accepted Time:
- 2019-04-10 19:45:47
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
886744 | Geron Corp | GERN | Pharmaceutical Preparations (2834) | 752287752 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1187032 | Kelly Melissa Behrs | C/O Geron Corporation 149 Commonwealth Drive, Suite 2070 Menlo Park CA 94025 | Evp, Chief Business Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2019-04-09 | 120,635 | $2.00 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- This transaction was conducted pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 18, 2018.